1. Canada Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Hypertension Diagnostics, Inc.

Hypertension Diagnostics, Inc.

HDII
Hypertension Diagnostics, Inc.US flagOther OTC
0.00
USD
- -
- -
13,681.00Market Cap
Hypertension Diagnostics, Inc.
HDII
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2016
2017
2018
TTM
FRC
0.08
0.38
0.09
0.09
0.05
0.04
0.05
0.05
0.01
0.01
0.03
- -
0.07
- -
- -
- -
- -
Revenue per Share
-0.65
-0.42
-1.07
-0.45
-0.08
-0.05
-0.04
-0.01
-0.02
-0.01
-0.02
0.01
-0.03
- -
- -
- -
-0.03
Basic EPS, GAAP
-0.74
-0.42
-0.69
-0.21
-0.07
-0.03
-0.02
-0.01
-0.01
-0.01
0.01
- -
-0.04
- -
- -
- -
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.71
-2.08
-2.95
-2.54
-1.06
-0.86
-0.73
-0.66
-0.67
-0.66
-0.68
-0.65
-0.61
- -
- -
- -
-0.58
Book Value per Share
1.04
0.99
0.42
0.01
0.07
0.06
0.05
0.04
0.02
0.02
- -
0.01
-0.01
- -
- -
- -
-0.03
Tangible Book Value per Share
5
5
6
8
22
29
35
40
40
41
41
43
47
- -
- -
- -
52
Basic Weighted Avg Shares
- -
2
1
1
1
1
2
2
1
1
1
- -
3
4
4
4
- -
Sales/Revenue/Turnover
-859.15
-120.15
-1,090.85
-462.31
-169.37
-125.85
-73.74
-29.85
-135.22
-51.99
9.83
- -
-43.08
-14.03
-6.66
0.02
-983.62
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-3
-2
-6
-4
-2
-1
-1
-1
-1
- -
-1
- -
-1
-1
- -
- -
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-784.98
-110.14
-1,159.81
-490.42
-171.24
-123.12
-71.12
-26.83
-126.94
-49.37
-71.53
- -
-40
-17.43
-10.02
-3.31
-863.06
Profit Margin (%)
5
5
2
- -
1
1
2
1
1
1
- -
- -
- -
-1
-1
-1
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
4
4
5
1
LT Debt
5
5
3
- -
2
2
2
1
1
1
- -
- -
- -
-4
-5
-5
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'16
Dec'16
Mar'16
ST Debt
- -
- -
- -
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
52
52
52
Market Capitalization
2
- -
1

Working Capital

FRC

•

in mil. unless spec.
Sep'16
Dec'16
Mar'16
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
64%
166.37%
2.71%
Free Cash Flow
59.91%
163.65%
341.59%
Net Income, GAAP
-50.9%
-141.89%
-65.98%
Sales/Revenue/Turnover
- -
- -
3.11%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
4
2018
- -
- -
- -
- -
4
2019
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
Similar Companies
Arisz Acquisition Corp. (ARIZU)
Live Oak Mobility Acquisition Corp. (LOKM-UN)
Gores Holdings VIII, Inc. (GIIX)
Vahanna Tech Edge Acquisition I Corp. (VHNAU)
Chavant Capital Acquisition Corp. (CLAYW)
Model Performance Acquisition Corp. (MPAC)
Business
Hypertension Diagnostics, Inc. (HDII) engages in the business of plastic reprocessing through its subsidiary HDi Plastics Inc., providing pelletized resin and clean shredded and ground plastics material to domestic manufacturing companies; the company exited its prior medical device operations focused on noninvasive cardiovascular profiling systems such as the CVProfilor DO-2020, CVProfilor MD-3000, and HD/PulseWave CR-2000 research system, which assessed arterial elasticity indices for physicians, researchers, and cardiovascular specialists. Founded in 1988 and headquartered at 550 Highway 7 East, Unit 316, Richmond Hill, Ontario, Canada L4B 3Z4, it originally developed proprietary medical devices to detect subtle changes in artery elasticity in the United States and internationally before shifting strategic focus. The company began plastics reprocessing operations in Austin, Texas, entered an agreement with China Specialty International Limited in April 2021 to support its new direction, and continues to serve the growing demand for reprocessed post-consumer and post-industrial plastic waste.

Company News

APIChat

  • defenseworld.net

    Critical Analysis: OPKO Health (NASDAQ:OPK) vs. Hypertension Diagnostics (OTCMKTS:HDII)